IKBKB and cystic fibrosis: miR-199a-3p was found downregulated in primary air-liquid interface cultures and bronchial explants from CF versus non-CF controls, and was demonstrated to regulate the expression of inhibitor of nuclear factor kappa-B kinase subunit beta (IKK-β), a signalling intermediary of the NF-κB pathway36.